Orgenesis Inc Financials
Orgenesis Inc (ORGS) reported $1.0M in revenue for fiscal year 2024, up 95.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Orgenesis now looks financing-dependent, with liabilities overwhelming assets as revenue remains too small to cover even direct costs.
Liquidity has deteriorated from a 2.9x current ratio in FY2022 to just 0.03x in FY2024, shifting the story from ordinary losses to short-term funding dependence. With only$78K of cash and a FY2024 gross margin of-86.3% , the business is not presently covering even direct delivery costs, much less near-term obligations.
FY2024 liabilities of
Cash needs appear driven more by ongoing operations than by expansion: FY2023 operating cash flow was
Financial Health Signals
Orgenesis Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Orgenesis Inc generated $1.0M in revenue in fiscal year 2024. This represents an increase of 95.3% from the prior year.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Cash & Balance Sheet
Orgenesis Inc held $78K in cash as of fiscal year 2024; long-term debt is not reported for that period.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Margins & Returns
Orgenesis Inc's gross margin was -86.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. No change is given against fiscal year 2023: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Capital Allocation
Orgenesis Inc invested $263K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 87.5% from the prior year.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
ORGS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $301K-13.3% | $347K+41.1% | $246K+74.5% | $141K-14.5% | $165K+50.0% | $110K-2.7% | $113K-20.4% | $142K |
| Cost of Revenue | $313K-46.5% | $585K+8.7% | $538K+9.3% | $492K+203.7% | $162K+16.5% | $139K-95.7% | $3.2M+18.7% | $2.7M |
| Gross Profit | -$12K+95.0% | -$238K+18.5% | -$292K+16.8% | -$351K-11800.0% | $3K+110.3% | -$29K+99.1% | -$3.1M-20.9% | -$2.6M |
| R&D Expenses | N/A | $4.5M+203.8% | $1.5M-37.2% | $2.4M-21.2% | $3.0M+272.2% | $808K-77.1% | $3.5M+7.5% | $3.3M |
| SG&A Expenses | N/A | $2.7M+29.3% | $2.1M-66.0% | $6.1M+182.3% | $2.1M+72.3% | $1.2M-93.2% | $18.2M+34.7% | $13.5M |
| Operating Income | N/A | -$8.4M-97.5% | -$4.3M+52.4% | -$8.9M-32.6% | -$6.7M-201.3% | -$2.2M+91.1% | -$25.1M-27.9% | -$19.6M |
| Income Tax | $44K+37.5% | $32K+540.0% | $5K-68.8% | $16K+111.3% | -$141K-135.8% | $394K+333.0% | $91K-29.5% | $129K |
| Net Income | N/A | -$9.1M-2.4% | -$8.9M+8.8% | -$9.8M-47.4% | -$6.6M-77.8% | -$3.7M+85.4% | -$25.5M-31.2% | -$19.5M |
| EPS (Diluted) | N/A | $1.93 | $0.23-20.7% | $0.29+38.1% | $0.21+75.0% | $0.12-84.2% | $0.76-12.6% | $0.87 |
Not reported in any period shown, so not listed: Interest Expense.
ORGS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4M-95.4% | $29.7M-2.9% | $30.6M-1.1% | $30.9M+112.5% | $14.6M-17.0% | $17.5M-3.0% | $18.1M-75.6% | $74.2M |
| Current Assets | $761K-69.8% | $2.5M+7.3% | $2.3M+20.0% | $2.0M-52.0% | $4.1M-31.8% | $6.0M-8.5% | $6.5M-78.5% | $30.3M |
| Cash & Equivalents | $78K-61.8% | $204K+164.9% | $77K-3.8% | $80K-90.4% | $837K+1421.8% | $55K-69.4% | $180K-93.3% | $2.7M |
| Inventory | N/A | N/A | N/A | $34K0.0% | $34K0.0% | $34K0.0% | $34K-73.4% | $128K |
| Accounts Receivable | $40K-75.2% | $161K-32.9% | $240K-2.0% | $245K+178.4% | $88K+23.9% | $71K+1083.3% | $6K-100.0% | $21.3M |
| Goodwill | N/A | $1.2M0.0% | $1.2M0.0% | $1.2M0.0% | $1.2M0.0% | $1.2M0.0% | $1.2M-85.0% | $8.1M |
| Total Liabilities | $38.9M-27.5% | $53.6M+15.6% | $46.4M-20.7% | $58.5M+64.5% | $35.5M+8.0% | $32.9M+6.8% | $30.8M-52.9% | $65.4M |
| Current Liabilities | $26.9M-25.3% | $36.0M+13.7% | $31.7M+9.2% | $29.0M+76.9% | $16.4M+14.7% | $14.3M+12.5% | $12.7M-8.8% | $13.9M |
| Total Equity | -$37.5M-56.9% | -$23.9M-54.2% | -$15.5M+44.1% | -$27.7M-32.1% | -$21.0M-36.5% | -$15.4M-20.7% | -$12.7M-246.1% | $8.7M |
| Retained Earnings | -$224.8M-10.0% | -$204.4M-4.7% | -$195.3M-4.8% | -$186.4M-5.5% | -$176.6M-3.9% | -$170.0M-2.2% | -$166.3M-18.2% | -$140.7M |
Not reported in any period shown, so not listed: Long-Term Debt.
ORGS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.1M+54.7% | -$4.6M+21.6% | -$5.9M-33.0% | -$4.4M-784.7% | -$502K+57.5% | -$1.2M+80.0% | -$5.9M+18.3% | -$7.2M |
| Capital Expenditures | $0-100.0% | $58K+5700.0% | $1K-99.5% | $204K | $0-100.0% | $300K-41.3% | $511K-60.2% | $1.3M |
| Free Cash Flow | -$2.1M+55.2% | -$4.7M+20.6% | -$5.9M-27.2% | -$4.6M-825.3% | -$502K+66.1% | -$1.5M+76.9% | -$6.4M+24.6% | -$8.5M |
| Investing Cash Flow | $292K+105.6% | $142K+14300.0% | -$1K+98.5% | -$68K-9.7% | -$62K+92.6% | -$843K+43.6% | -$1.5M-14.4% | -$1.3M |
| Financing Cash Flow | $1.4M-68.5% | $4.4M-31.9% | $6.5M+80.2% | $3.6M+195.0% | $1.2M-23.3% | $1.6M-67.3% | $4.9M-17.3% | $5.9M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
ORGS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -4.0%+64.6pp | -68.6% | -118.7% | -248.9% | 1.8%+28.2pp | -26.4% | -2760.2% | -1816.9% |
| Operating Margin | N/A | -2419.0% | -1727.6% | -6333.3% | -4081.8% | -2031.8% | -22185.8% | -13800.0% |
| Net Margin | N/A | -2628.2% | -3619.5% | -6925.5% | -4013.9% | -3386.4% | -22604.4% | -13711.3% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -223.4% |
| Return on Assets | N/A | -30.7%-1.6pp | -29.1%+2.5pp | -31.6%+13.9pp | -45.5%-24.3pp | -21.3%+120.1pp | -141.4%-115.1pp | -26.3% |
| Current Ratio | 0.030.0x | 0.070.0x | 0.070.0x | 0.07-0.2x | 0.25-0.2x | 0.42-0.1x | 0.51-1.7x | 2.18 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 7.51 |
| FCF Margin | -697.0% | -1351.0% | -2401.6% | -3294.3% | -304.2% | -1346.4% | -5685.8% | -6003.5% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$37.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Orgenesis Inc Ranks
Frequently Asked Questions
What is Orgenesis Inc's annual revenue?
Orgenesis Inc (ORGS) reported $1.0M in total revenue for fiscal year 2024. This represents a 95.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Orgenesis Inc's revenue growing?
Orgenesis Inc (ORGS) revenue grew by 95.3% year-over-year, from $530K to $1.0M in fiscal year 2024.
What is Orgenesis Inc's gross margin?
Orgenesis Inc (ORGS) had a gross margin of -86.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What are Orgenesis Inc's total assets?
Orgenesis Inc (ORGS) had $1.4M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Orgenesis Inc's capital expenditures?
Orgenesis Inc (ORGS) invested $263K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is Orgenesis Inc's current ratio?
Orgenesis Inc (ORGS) had a current ratio of 0.03 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
Why is Orgenesis Inc's debt-to-equity ratio negative or not reported?
Orgenesis Inc (ORGS) has negative shareholder equity of -$37.5M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.